SIRTEX
Live / Registered — Registered — Section 71 accepted (as of 15 Jun 2022)
What this means for you
Registered since 04 Dec 2012. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79109037
- Registration number
- 4252171
- Mark type
- Stylized text
- Filed
- 24 Oct 2011
- Published for opposition
- 18 Sept 2012
- Registered
- 04 Dec 2012
- Attorney of record
- Gwenn Roos
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the treatment of cancer; capsules and particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for veterinary purposes for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials containing radioactive material for medical therapeutic use for the treatment of cancer; microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; microcapsules and microparticles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials and microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer
- Class 042 — Scientific and technological services: Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology
Owner
- Sirtex Medical Limited, NORTH SYDNEY, AU
- Sirtex Medical Limited, AU
- Sirtex Medical Limited, AU
Prosecution history
- 18 Feb 2025 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 31 Aug 2024 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 15 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 15 Jun 2022 — REGISTERED-SEC.71 ACCEPTED
- 31 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 May 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 09 May 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 02 Apr 2022 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 02 Apr 2022 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 05 Dec 2021 — TEAS SECTION 71 RECEIVED
- 04 Dec 2021 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 11 Nov 2021 — INTERNATIONAL REGISTRATION RENEWED
- 09 Apr 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 27 Dec 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Dec 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED